Study title: Treatment of congenital cytomegalovirus: where are we now? Expert Review of Antiinfective Therapy 2007; 5(3):441-448Treatment of congenital cytomegalovirus: where are we now? Expert Review of Antiinfective Therapy 2007; 5(3):441-448
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Virus Diseases [C02] | |||||
Brands: Please see report, Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: FOSCARNET | |||||
ATC code: | |||||
Document link: Michaels MG 2007.pdf | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Review Article | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | Y | - | - | - |